Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Cominelli

Showing results (41-50 of 200) with videos related to

Pageof 20
Sort By:
Gastroenterology Clinics of North America|November 28, 2017
Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation ApproachesAbigail R Basson, Minh Lam, Fabio Cominelli
Inflammatory Bowel Diseases|December 14, 2021
Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel DiseaseGiorgos Bamias, Theresa T Pizarro, Fabio Cominelli
Immunology Letters|June 19, 2014
Inflammatory bowel diseaseDaniele Corridoni, Kristen O Arseneau, Fabio Cominelli
Inflammatory Bowel Diseases|December 23, 2017
Changes, Changes, ChangesBret Lashner, Fabio Cominelli, Ashley Petrylak, et al.
Gastroenterology|April 2, 2021
Artificial Sweeteners and Whole-Food Science: Could Mice Help Clinicians Make Diet Recommendations for IBD Patients?Alexander Rodriguez-Palacios, Abigail Raffner Basson, Fabio Cominelli
Frontiers in Nutrition|October 11, 2021
Artificial Sweeteners: History and New Concepts on InflammationAbigail Raffner Basson, Alexander Rodriguez-Palacios, Fabio Cominelli
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 18, 2004
Differential contribution of IL-1Ra isoforms to allele-specific IL-1Ra mRNA accumulationKaren H Redlitz, Vladimir F Yamshchikov, Fabio Cominelli
Journal of Leukocyte Biology|June 25, 2013
RIP2 activity in inflammatory disease and implications for novel therapeuticsJanice C Jun, Fabio Cominelli, Derek W Abbott
Current Opinion in Investigational Drugs (London, England : 2000)|February 5, 2004
The Th1 immune pathway as a therapeutic target in Crohn's diseaseGiorgos Bamias, Kazuhiko Sugawara, Cristiano Pagnini, et al.
Current Gastroenterology Reports|November 7, 2003
Future therapies for inflammatory bowel diseaseStephen J Bickston, Lawrence W Comerford, Fabio Cominelli
Pageof 20

Showing results (41-50 of 200) with videos related to

Sort By:
Pageof 20
Gastroenterology Clinics of North America|November 28, 2017
Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation ApproachesAbigail R Basson, Minh Lam, Fabio Cominelli
Inflammatory Bowel Diseases|December 14, 2021
Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel DiseaseGiorgos Bamias, Theresa T Pizarro, Fabio Cominelli
Immunology Letters|June 19, 2014
Inflammatory bowel diseaseDaniele Corridoni, Kristen O Arseneau, Fabio Cominelli
Inflammatory Bowel Diseases|December 23, 2017
Changes, Changes, ChangesBret Lashner, Fabio Cominelli, Ashley Petrylak, et al.
Gastroenterology|April 2, 2021
Artificial Sweeteners and Whole-Food Science: Could Mice Help Clinicians Make Diet Recommendations for IBD Patients?Alexander Rodriguez-Palacios, Abigail Raffner Basson, Fabio Cominelli
Frontiers in Nutrition|October 11, 2021
Artificial Sweeteners: History and New Concepts on InflammationAbigail Raffner Basson, Alexander Rodriguez-Palacios, Fabio Cominelli
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 18, 2004
Differential contribution of IL-1Ra isoforms to allele-specific IL-1Ra mRNA accumulationKaren H Redlitz, Vladimir F Yamshchikov, Fabio Cominelli
Journal of Leukocyte Biology|June 25, 2013
RIP2 activity in inflammatory disease and implications for novel therapeuticsJanice C Jun, Fabio Cominelli, Derek W Abbott
Current Opinion in Investigational Drugs (London, England : 2000)|February 5, 2004
The Th1 immune pathway as a therapeutic target in Crohn's diseaseGiorgos Bamias, Kazuhiko Sugawara, Cristiano Pagnini, et al.
Current Gastroenterology Reports|November 7, 2003
Future therapies for inflammatory bowel diseaseStephen J Bickston, Lawrence W Comerford, Fabio Cominelli
Pageof 20